目次
1. 方法論と範囲
1.1. 調査方法
1.2. 調査目的と調査範囲
2. 定義と概要
3. エグゼクティブ・サマリー
3.1. ソース別スニペット
3.2. タイプ別スニペット
3.3. 形式別スニペット
3.4. 用途別スニペット
3.5. エンドユーザー別スニペット
3.6. 地域別スニペット
4. ダイナミクス
4.1. 影響要因
4.1.1. 推進要因
4.1.1.1. 健康効果に対する消費者の意識の高まり
4.1.1.2. 製剤数の増加
4.1.2. 阻害要因
4.1.2.1. より安価な合成乳化剤の入手可能性
4.1.3. 機会
4.1.4. 影響分析
5. 産業分析
5.1. ポーターのファイブフォース分析
5.2. 規制分析
5.3. 価格分析
5.4. 特許分析
5.5. SWOT分析
5.6. サプライチェーン分析
5.7. バリューチェーン分析
5.8. 輸出入分析
5.9. 臨床試験分析
5.10. 消費者分析
5.11. 持続可能性分析
5.12. ヒートマップ
5.13. B2B分析
6. ソース別
6.1. はじめに
6.1.1. ソース別市場規模分析および前年比成長率分析（%）.
6.1.2. 市場魅力度指数, 供給源別
6.2. 植物由来
6.2.1. はじめに
6.2.2. 市場規模分析と前年比成長率分析(%)
6.2.3. 大豆
6.2.4. ひまわり
6.2.5. 菜種（カノーラ）
6.3. 動物性
6.3.1. モルモット
6.3.2. ウシ
7. 種類別
7.1. はじめに
7.1.1. 市場規模分析および前年比成長率分析（%）, タイプ別
7.1.2. 市場魅力度指数（タイプ別
7.2. 加水分解リゾレシチン*市場
7.2.1. はじめに
7.2.2. 市場規模分析と前年比成長率分析(%)
7.2.3. 加水分解液
7.2.4. 脱油加水分解
7.3. 化学修飾リゾレシチン
7.4. その他
8. 形態別
8.1. 導入
8.1.1. 市場規模分析および前年比成長率分析（%）, 形態別
8.1.2. 市場魅力度指数（形態別
8.2. 粉末*市場
8.2.1. はじめに
8.2.2. 市場規模分析と前年比成長率分析(%)
8.3. 液体
8.4. 顆粒
9. 用途別
9.1. はじめに
9.1.1. 市場規模分析および前年比成長率分析（%）, アプリケーション別
9.1.2. 市場魅力度指数（用途別
9.2. 菓子*市場
9.2.1. 序論
9.2.2. 市場規模分析と前年比成長率分析(%)
9.3. ベーカリー
9.4. 食品サプリメント
9.5. 飼料
9.6. 乳製品
9.7. パーソナルケア及び化粧品
9.8. 植物ベースの代替品
9.9. その他
10. エンドユーザー別
10.1. はじめに
10.1.1. 市場規模分析および前年比成長率分析(%), エンドユーザー別
10.1.2. 市場魅力度指数、エンドユーザー別
10.2. 食品・飲料*市場
10.2.1. 序論
10.2.2. 市場規模分析と前年比成長率分析(%)
10.3. 医薬品
10.4. 化粧品
10.5. 栄養補助食品
11. 地域別
11.1. はじめに
11.1.1. 地域別市場規模分析および前年比成長率分析(%)
11.1.2. 市場魅力度指数、地域別
11.2. 北米
11.2.1. 序論
11.2.2. 主な地域別ダイナミクス
11.2.3. 市場規模分析およびYoY成長率分析(%), 供給源別
11.2.4. 市場規模分析および前年比成長率分析（%）, タイプ別
11.2.5. 市場規模分析および前年比成長率分析（%）, 形態別
11.2.6. 市場規模分析および前年比成長率分析（%）, 用途別
11.2.7. 市場規模分析および前年比成長率分析（%）, エンドユーザー別
11.2.8. 市場規模分析および前年比成長率分析(%)、国別
11.2.8.1. 米国
11.2.8.2. カナダ
11.2.8.3. メキシコ
11.3. ヨーロッパ
11.3.1. はじめに
11.3.2. 主な地域別動向
11.3.3. 市場規模分析およびYoY成長率分析(%), 供給源別
11.3.4. 市場規模分析および前年比成長率分析（%）, タイプ別
11.3.5. 市場規模分析および前年比成長率分析（%）, 形状別
11.3.6. 市場規模分析および前年比成長率分析（%）, 用途別
11.3.7. 市場規模分析および前年比成長率分析（%）, エンドユーザー別
11.3.8. 市場規模分析および前年比成長率分析(%)、国別
11.3.8.1. ドイツ
11.3.8.2. イギリス
11.3.8.3. フランス
11.3.8.4. イタリア
11.3.8.5. スペイン
11.3.8.6. その他のヨーロッパ
11.4. 南米
11.4.1. はじめに
11.4.2. 地域別主要市場
11.4.3. 市場規模分析およびYoY成長率分析(%), 供給源別
11.4.4. 市場規模分析と前年比成長率分析（%）, タイプ別
11.4.5. 市場規模分析および前年比成長率分析（%）, 形態別
11.4.6. 市場規模分析および前年比成長率分析（%）, 用途別
11.4.7. 市場規模分析および前年比成長率分析（%）, エンドユーザー別
11.4.8. 市場規模分析および前年比成長率分析(%)、国別
11.4.8.1. ブラジル
11.4.8.2. アルゼンチン
11.4.8.3. その他の南米諸国
11.5. アジア太平洋
11.5.1. はじめに
11.5.2. 主な地域別ダイナミクス
11.5.3. 市場規模分析および前年比成長率分析(%)、供給源別
11.5.4. 市場規模分析および前年比成長率分析（%）, タイプ別
11.5.5. 市場規模分析および前年比成長率分析（%）, フォーム別
11.5.6. 市場規模分析および前年比成長率分析（%）, 用途別
11.5.7. 市場規模分析および前年比成長率分析（%）, エンドユーザー別
11.5.8. 市場規模分析および前年比成長率分析(%)、国別
11.5.8.1. 中国
11.5.8.2. インド
11.5.8.3. 日本
11.5.8.4. オーストラリア
11.5.8.5. その他のアジア太平洋地域
11.6. 中東・アフリカ
11.6.1. 序論
11.6.2. 主な地域別ダイナミクス
11.6.3. 市場規模分析およびYoY成長率分析(%), 供給源別
11.6.4. 市場規模分析および前年比成長率分析（%）, タイプ別
11.6.5. 市場規模分析および前年比成長率分析（%）, フォーム別
11.6.6. 市場規模分析および前年比成長率分析 (%)、用途別
11.6.7. 市場規模分析および前年比成長率分析（%）, エンドユーザー別
12. 競合情勢
12.1. 競争シナリオ
12.2. 市場ポジショニング／シェア分析
12.3. M&A分析
13. 企業プロフィール
13.1. Kemin Industries, Inc.*
13.1.1. 会社概要
13.1.2. 製品ポートフォリオと内容
13.1.3. 財務概要
13.1.4. 主な展開
13.2. Cargill, Inc.
13.3. Lipoid GmbH
13.4. Sternchemie GmbH & Co. KG
13.5. Alexmo Cosmetics
13.6. Cayman Chemical
13.7. Creative Biolabs
13.8. GlpBio Technology
13.9. Larodan AB
13.10. Biosynth Ltd
リストは網羅的ではありません
14. 付録
14.1. 会社概要とサービス
14.2. お問い合わせ
The Global Lysolecithin Market reached US$ 157.5 million in 2023 and is expected to reach US$ 284.3 million by 2031, growing at a CAGR of 7.7% during the forecast period 2024-2031.
Lysolecithin possesses unique characteristics, including its capacity to form micelles and liposomes, which make it a promising option for drug delivery systems. Researchers are investigating the potential of lysolecithin to encapsulate and transport various active pharmaceutical ingredients, intending to enhance their bioavailability and therapeutic effectiveness.
Further, key players in the industry launching innovative products that would drive this market growth. For instance, Kemin Industries, Inc. introduced LYSOFORTE a nutritional emulsifier derived from lysophospholipids, specifically designed to enhance the digestion and absorption of energy-dense feed components such as fats, oils and fat-soluble nutrients in livestock and poultry diets. Its innovative formulation optimizes three essential stages of fat digestion: emulsification, hydrolysis and absorption.
Dynamics
Rising Consumer Awareness of Health Benefits
The demand for the global lysolecithin market is driven by multiple factors. One of the key factors is the rising consumer awareness of health benefits. Consumer awareness of lysolecithin’s health benefits is significantly influencing its incorporation into various products across multiple sectors, particularly in the global market. Studies indicate that lysolecithin may improve brain health and cognitive function, making it appealing to consumers who want to boost mental clarity and memory, particularly within aging populations.
The growing preference for natural and non-GMO ingredients has made lysolecithin a favored option in clean-label products. Health-conscious consumers are increasingly looking for items with familiar ingredients that match their dietary choices. Lysolecithin's adaptability enables its incorporation into a wide variety of products across several sectors, including food and beverages, nutraceuticals and personal care.
Ongoing advancements and innovations in biotechnology and life sciences are creating new opportunities for the use of lysolecithin, especially in the areas of medicine and health-related products. As consumers grow more health-conscious, there is a significant rise in the demand for functional foods and dietary supplements that offer targeted health benefits.
Moreover, key players in the industry product launches and Key Developments that would drive this market growth. For instance, in August 2023, Nikko Chemicals launched Nikkol Lecinol MFL, a product aimed at enhancing the skin's barrier function by stimulating the production of ceramides and filaggrin. This ingredient is rich in lysophosphatidic acid, a type of lysolecithin known for its extensive efficacy on epidermal cells.
Increasing Number of Drug Formulations
As drug development continues to advance, lysolecithin is gaining popularity for its properties as an emulsifier, solubilizer and stabilizer, which are crucial in enhancing the effectiveness of drug delivery systems. The pharmaceutical industry is constantly developing new formulations that require improved bioavailability, controlled release and enhanced absorption of active ingredients.
Lysolecithin, being a natural phospholipid, is used to improve the solubility of hydrophobic drugs, making it a preferred choice in various drug formulations. Its ability to form liposomes and stabilize emulsions enhances the delivery and absorption of medications, which is particularly important in oral, topical and injectable drug applications.
As the demand for more complex drug formulations rises in the pharmaceutical market, the need for functional ingredients like lysolecithin increases. Furthermore, the trend toward personalized medicine, which often involves specialized drug delivery systems, is expected to boost the use of lysolecithin in the market. Pharmaceutical companies are leveraging lysolecithin to create more effective and patient-friendly drug products, thereby driving the global lysolecithin market's growth.
Availability of Cheaper Synthetic Emulsifiers
Synthetic emulsifiers such as polysorbates, mono- and diglycerides and others are widely available at lower costs compared to natural alternatives like lysolecithin. These synthetic emulsifiers often provide similar functional benefits, such as improving texture, stability and shelf life in food, cosmetic and pharmaceutical products. As a result, manufacturers seeking to reduce costs are inclined to choose these lower-priced options over lysolecithin, especially in price-sensitive markets like processed foods and mass-market personal care products.
Additionally, the production of synthetic emulsifiers tends to be more scalable and less affected by the agricultural supply chain, which often impacts the availability and pricing of natural lysolecithin. This further solidifies the position of synthetic emulsifiers in the market, as they can be produced at a consistent quality and quantity, giving them an edge over their natural counterparts.
Segment Analysis
The global lysolecithin market is segmented based on source, type, form, application, end-user and region.
Diverse Applications and Various Health Benefits of Soy
Soy lysolecithin has become a widely used emulsifier in various food products due to its ability to enhance texture, stability and shelf life. It plays a vital role across various sectors, including food, pharmaceuticals and cosmetics. With consumers increasingly favoring healthier and more natural products, the demand for soy lysolecithin is anticipated to keep rising, growing because of its diverse applications and various health benefits. This trend creates substantial opportunities for manufacturers and suppliers in the lysolecithin market.
Soy lysolecithin is being explored for its potential use in drug delivery systems. Its distinctive characteristics allow it to serve as an effective medium for encapsulating active pharmaceutical ingredients, thereby improving their bioavailability and therapeutic effectiveness. Moreover, key players in the industry introduce various products in multiple sectors and Key Developments that would propel this segment’s growth in the market.
For instance, in January 2024, Cosphatec launched two new products, Cosphaderm E NGM Natural and Cosphaderm PA-12, that adhere to the COSMOS and NATRUE certification standards for natural and organic cosmetic ingredients. This launch underscores Cosphatec's dedication to providing sustainable and eco-friendly raw materials for the cosmetics industry. Cosphaderm E NGM Natural is a liquid lysolecithin derived from soybeans.
Lysolecithin is an enzymatically modified form of lecithin, where a fatty acid has been removed through enzymatic processing. This modification results in a product with enhanced properties compared to regular lecithin. Similarly, Amitex India introduced the AmiLife Enzymatically Hydrolyzed Soya Lecithin (E322). It is derived from non-GMO soy lecithin. Through enzymatic hydrolysis, this lecithin undergoes modification to optimize its functional properties, making it suitable for diverse applications in the food industry and animal nutrition sectors.
Geographical Penetration
Expansion of the Food Processing Industry in Asia-Pacific
The increasing consumer preference for natural and non-GMO ingredients in food products is a prominent trend, especially in countries like India and China. As consumers in these regions become more health-conscious, they actively seek products that align with their dietary choices. Lysolecithin, which is derived from soy lecithin, fulfills these demands as it is viewed as a healthier alternative to synthetic emulsifiers.
The rapid expansion of the food processing industry in the Asia-Pacific region is a major factor driving the demand for lysolecithin as an emulsifier. Lysolecithin is extensively utilized in various food products, including baked goods, dairy items and convenience foods. The increasing consumption of processed and ready-to-eat meals, fueled by changing lifestyles and urbanization, has further heightened the need for effective emulsifiers like lysolecithin.
As urbanization progresses and consumer habits shift towards more convenient food options, the role of lysolecithin in food formulations is expected to grow, catering to both manufacturers' requirements and consumers' desires for high-quality processed foods. There is a rising awareness of the health advantages associated with lysolecithin, such as its capacity to improve cognitive function, lower cholesterol levels and support liver health helps to propel this market growth in this region.
Key player strategies such as partnerships & collaborations and technological advancements would drive this market growth. For instance, Prathista Industries has introduced a non-hormonal and naturally occurring feed supplement known as Pro-Lyso (Lysolecithin), developed in collaboration with the Indian Institute of Chemical Technology (IICT) in Hyderabad. This innovative product utilizes established biotechnology processes to enhance animal nutrition, specifically targeting poultry and shrimp.
Competitive Landscape
Bifurcation of how emerging players and startups function in the market
Emerging players and startups play a crucial role in the evolving lysolecithin market. While established players dominate large portions of the market, newer entrants are bringing innovation, agility and unique business models that challenge traditional supply chains. Many startups work closely with academic or research institutions to leverage the latest technological advancements in enzymatic processing or sustainable production methods. By adopting cutting-edge processes, they can produce high-quality lysolecithin at lower costs or with enhanced functionality, giving them a competitive advantage.
Market Presence: While startups are only entering the market, emerging players have made a name for themselves with their current offerings.
Resources: While startups frequently work with a small amount of cash, emerging players usually have access to additional resources, such as supply chains and finance.
Innovation Focus: While emerging players expand on previously developed ideas, Startups are catering to the growing demand for plant-based foods, positioning their lysolecithin products as natural emulsifiers in plant-based meat, dairy alternatives and clean-label processed foods. These companies are branding themselves as enablers of sustainable, ethical food production.
Brand Recognition: While startups are still developing their reputation and recognition in the industry, emerging players already have a certain amount of brand awareness. Startups use digital platforms to build their brand identity, often focusing on ethical sourcing, sustainability and transparency.
The major global players in the market include Kemin Industries, Inc., Cargill, Inc., Lipoid GmbH, Sternchemie GmbH & Co. KG, Alexmo Cosmetics, Cayman Chemical, Creative Biolabs, GlpBio Technology, Larodan AB and Biosynth Ltd.
Aim of trial: The objectives of this study were to evaluate three different strategies of LYSO supplementation on feedlot performance, carcass characteristics, nutrient digestion and the longissimus fatty acid profile of Bos indicus and Bos indicus crosses and to validate an innovative environmental index named InComfort (InCl) as a tool to evaluate DMI during natural heat stress events in the course of conducting open dry-lot feedlot experiments.
Materials and methods: All procedures and protocols involving the use of animals were approved by the Ethics Committee on animal use of the São Paulo State University “Julio de Mesquita Filho” (UNESP; Protocol number: 016339/19).
Results: In experiment (1), no differences were detected for IBW (P = 0.791). The use of LYSO increased FBW (P = 0.022); however, no differences were detected among the LYSO phase-feeding treatments (P = 0.191). Conversely, a tendency was observed (P = 0.060) when NON was compared with the pairwise comparisons of the means (GRO). In experiment (2), a treatment × breed interaction was observed, in which CEA animals had a higher IBW (P < 0.001; 406.42 vs. 372.55 for CEA and NEL, respectively); however, no differences were detected for FBW (P = 0.223; data not shown). Moreover, NEL animals from FIN also had greater DMI (P < 0.05) than NON, GRO and ALL cohorts within the same genotype but did not differ from CEA in the ALL and GRO protocols.
Conclusion: Overall, feeding LYSO during growing period (GRO) and finishing period (FIN) enhanced feedlot performance and should lead to higher intakes during very hot days of the finishing feeding period.
Consumer Analysis
Consumer analysis in the lysolecithin market helps to understand the behavior, preferences and needs of the market's various consumer segments. This analysis focuses on identifying the main industries and end-users of lysolecithin, their purchasing drivers, key concerns and the factors influencing their decision-making processes.
Consumers, particularly in the food, cosmetics and nutraceutical industries, increasingly prefer products that are natural, minimally processed and free from artificial additives. Lysolecithin, derived from natural sources like soybeans and sunflower seeds, aligns well with this trend. Although lysolecithin is favored for its natural properties, price remains a critical factor, particularly for large-scale users in the food and feed industries. Fluctuations in the prices of raw materials can significantly impact consumer purchasing decisions.
Sustainability Analysis
Sustainability is becoming a central focus for companies operating in the lysolecithin market. As industries worldwide move toward environmentally responsible practices, the lysolecithin market is being shaped by efforts to address environmental, social and governance factors. Sustainability in this market encompasses several areas, such as responsible sourcing of raw materials, eco-friendly production processes, reducing carbon footprints and offering products that align with consumer demand for clean-label, natural ingredients.
Cargill has been working to end deforestation related to soy production for more than 20 years. They promote sustainable practices to meet the world’s growing demand for soy in food, animal feed and biofuels driven by increasing nutritional needs, changing dietary habits and desire for fossil-fuel alternatives. Cargill’s role in the soy supply chain comes with significant responsibility and they are keenly aware of the need to deliver customer solutions in a safe, responsible and sustainable way.
By Source
• Plant Based
o Soy
o Sunflower
o Rapeseed (Canola)
• Animal Based
o Guinea Pig
o Bovine
By Type
• Hydrolyzed Lysolecithin
o Fluid Hydrolyzed
o De-oiled Hydrolyzed
• Chemically Modified Lysolecithin
• Others
By Form
• Powder
• Liquid
• Granules
By Application
• Confectionery
• Bakery
• Food Supplements
• Animal Feed
• Dairy Products
• Personal Care and Cosmetics
• Plant Based Alternatives
• Others
By End-User
• Food and Beverage
• Pharmaceuticals
• Cosmetics
• Nutraceuticals
By Region
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o France
o Italy
o Spain
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o Australia
o Rest of Asia-Pacific
• Middle East and Africa
Key Developments
• In January 2024, Cosphatec launched two new products, Cosphaderm E NGM Natural and Cosphaderm PA-12, that adhere to the COSMOS and NATRUE certification standards for natural and organic cosmetic ingredients. This launch underscores Cosphatec's dedication to providing sustainable and eco-friendly raw materials for the cosmetics industry. Cosphaderm E NGM Natural is a liquid lysolecithin derived from soybeans.
• In 2023, Prathista Industries introduced a non-hormonal and naturally occurring feed supplement known as Pro-Lyso (Lysolecithin), developed in collaboration with the Indian Institute of Chemical Technology (IICT) in Hyderabad. This innovative product utilizes established biotechnology processes to enhance animal nutrition, specifically targeting poultry and shrimp.
• In July 2022, Amitex India introduced the AmiLife Enzymatically Hydrolyzed Soya Lecithin (E322). It is derived from non-GMO soy lecithin. Through enzymatic hydrolysis, this lecithin undergoes modification to optimize its functional properties, making it suitable for diverse applications in the food industry and animal nutrition sectors.
Why Purchase the Report?
• To visualize the global lysolecithin market segmentation based on source, type, form, application, end-user and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of the global lysolecithin market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global Lysolecithin market report would provide approximately 78 tables, 77 figures and 215 pages.
Target Audience 2024
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies
Table of Contents
1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Source
3.2. Snippet by Type
3.3. Snippet by Form
3.4. Snippet by Application
3.5. Snippet by End-User
3.6. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rising Consumer Awareness of Health Benefits
4.1.1.2. Increasing Number of Drug Formulations
4.1.2. Restraints
4.1.2.1. Availability of Cheaper Synthetic Emulsifiers
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Regulatory Analysis
5.3. Pricing Analysis
5.4. Patent Analysis
5.5. SWOT Analysis
5.6. Supply Chain Analysis
5.7. Value Chain Analysis
5.8. Import and Export Analysis
5.9. Clinical Trial Analysis
5.10. Consumer Analysis
5.11. Sustainability Analysis
5.12. Heat Maps
5.13. B2B Analysis
6. By Source
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
6.1.2. Market Attractiveness Index, By Source
6.2. Plant Based*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.2.3. Soy
6.2.4. Sunflower
6.2.5. Rapeseed (Canola)
6.3. Animal Based
6.3.1. Guinea Pig
6.3.2. Bovine
7. By Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
7.1.2. Market Attractiveness Index, By Type
7.2. Hydrolyzed Lysolecithin*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.2.3. Fluid Hydrolyzed
7.2.4. De-oiled Hydrolyzed
7.3. Chemically Modified Lysolecithin
7.4. Others
8. By Form
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
8.1.2. Market Attractiveness Index, By Form
8.2. Powder*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Liquid
8.4. Granules
9. By Application
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.1.2. Market Attractiveness Index, By Application
9.2. Confectionery*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Bakery
9.4. Food Supplements
9.5. Animal Feed
9.6. Dairy Products
9.7. Personal Care and Cosmetics
9.8. Plant Based Alternatives
9.9. Others
10. By End-User
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.1.2. Market Attractiveness Index, By End-User
10.2. Food and Beverage*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Pharmaceuticals
10.4. Cosmetics
10.5. Nutraceuticals
11. By Region
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.2.8.1. US
11.2.8.2. Canada
11.2.8.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.3.8.1. Germany
11.3.8.2. UK
11.3.8.3. France
11.3.8.4. Italy
11.3.8.5. Spain
11.3.8.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.4.8.1. Brazil
11.4.8.2. Argentina
11.4.8.3. Rest of South America
11.5. Asia-Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.5.8.1. China
11.5.8.2. India
11.5.8.3. Japan
11.5.8.4. Australia
11.5.8.5. Rest of Asia-Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis
13. Company Profiles
13.1. Kemin Industries, Inc.*
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Financial Overview
13.1.4. Key Developments
13.2. Cargill, Inc.
13.3. Lipoid GmbH
13.4. Sternchemie GmbH & Co. KG
13.5. Alexmo Cosmetics
13.6. Cayman Chemical
13.7. Creative Biolabs
13.8. GlpBio Technology
13.9. Larodan AB
13.10. Biosynth Ltd
LIST NOT EXHAUSTIVE
14. Appendix
14.1. About Us and Services
14.2. Contact Us
*** リゾレシチンの世界市場に関するよくある質問(FAQ) ***
・リゾレシチンの世界市場規模は？
→DataM Intelligence社は2023年のリゾレシチンの世界市場規模を1億5,750万米ドルと推定しています。
・リゾレシチンの世界市場予測は？
→DataM Intelligence社は2031年のリゾレシチンの世界市場規模を2億8,430万米ドルと予測しています。
・リゾレシチン市場の成長率は？
→DataM Intelligence社はリゾレシチンの世界市場が2024年～2031年に年平均7.7%成長すると展望しています。
・世界のリゾレシチン市場における主要プレイヤーは？
→「Kemin Industries, Inc.、Cargill, Inc.、Lipoid GmbH、Sternchemie GmbH & Co. KG、Alexmo Cosmetics、Cayman Chemical、Creative Biolabs、GlpBio Technology、Larodan AB、Biosynth Ltd.など ...」をリゾレシチン市場のグローバル主要プレイヤーとして判断しています。
※上記FAQの市場規模、市場予測、成長率、主要企業に関する情報は本レポートの概要を作成した時点での情報であり、最終レポートの情報と少し異なる場合があります。
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
